STOCK TITAN

Paragon 28 to Present at Upcoming Canaccord Genuity Musculoskeletal Conference and Needham Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Paragon 28, Inc. (NYSE: FNA), a premier medical device company focusing on foot and ankle orthopedics, announced presentations by CEO Albert DaCosta and CFO Steve Deitsch at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022, and the Needham Healthcare Conference on April 11, 2022. Both events will be webcast live, with the Canaccord chat at 12:30pm ET and the Needham chat at 11:00am ET. Archived recordings will be available on the company’s investor relations website.

Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will be presenting at the Canaccord Genuity Musculoskeletal Conference on March 22nd and 2022 Needham Healthcare Conference on April 11th.

The Canaccord Genuity fireside chat will be webcast live on March 22, 2022, at 12:30pm ET / 9:30am PT. The Needham fireside chat will be webcast live on April 11, 2022, at 11:00am ET / 8:00am PT. Each webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Gilmartin Group

Matt Bacso, CFA

matt.bacso@gilmartinir.com

Source: Paragon 28, Inc.

FAQ

What is the date of Paragon 28's presentation at the Canaccord Genuity Musculoskeletal Conference?

Paragon 28 will present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022.

When will the Needham Healthcare Conference presentation take place for Paragon 28?

The Needham Healthcare Conference presentation for Paragon 28 is scheduled for April 11, 2022.

What time will Paragon 28's Canaccord Genuity fireside chat be webcast?

The Canaccord Genuity fireside chat will be webcast live at 12:30pm ET.

What time is the Needham fireside chat for Paragon 28?

The Needham fireside chat will be webcast live at 11:00am ET.

Where can I find the archived webcasts of Paragon 28's presentations?

Archived recordings of Paragon 28's presentations will be available on the investor relations section of their website.

What is the primary focus of Paragon 28 as a medical device company?

Paragon 28 focuses exclusively on the foot and ankle orthopedic market, offering innovative solutions for various ailments.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

831.64M
49.79M
40.56%
61.27%
8.11%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD